Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

358.66
-0.9250-0.26%
Post-market: 358.59-0.0650-0.02%18:28 EDT
Volume:351.28K
Turnover:125.69M
Market Cap:40.89B
PE:64.17
High:360.21
Open:351.73
Low:351.41
Close:359.58
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:85.69M
Volume Ratio:1.22
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:7.90
PE(LYR):145.20

Loading ...

BeOne Medicines (ONC) Gets a Buy from J.P. Morgan

TIPRANKS
·
May 20

BEIGENE Shares Rise Nearly 3% on FDA Accelerated Approval for Sotoklara and Strong Q1 Earnings Beat

Stock News
·
May 20

Major Financial Institutions Bullish on BEIGENE, Q1 Performance Confirms Long-Term Investment Value

Stock News
·
May 19

Beone Medicines : Leerink Partners Raises Target Price to $367 From $364

THOMSON REUTERS
·
May 15

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BeOne Medicines (ONC) and Nektar Therapeutics (NKTR)

TIPRANKS
·
May 14

BEIGENE's BEQALZI™ Secures FDA Accelerated Approval as First and Only BCL2 Inhibitor for Relapsed/Refractory Mantle Cell Lymphoma in the U.S.

Stock News
·
May 14

BeOne Medicines’ Beqalzi granted accelerated approval by FDA

TIPRANKS
·
May 14

BeOne Medicines Gets FDA Accelerated Approval for Lymphoma Drug

Dow Jones
·
May 14

BEIGENE Announces Grant of Restricted Stock Units

Stock News
·
May 13

BEIGENE Reports Q1 Profit Turnaround with 1.6 Billion Yuan Net Income

Stock News
·
May 11

CICC Maintains Outperform Rating on BEIGENE with HK$250 Target Price

Stock News
·
May 08

Leadership Reshuffle Sweeps Pharmaceutical Sector: Hengrui, Fosun, AstraZeneca, Pfizer Among Key Players

Deep News
·
May 07

BeOne Medicines Shares Surge After Robust First-Quarter

Dow Jones
·
May 07

BEIGENE's Q1 Net Profit Soars 399% Sequentially, Shares Jump 7% Post-Earnings

Deep News
·
May 07

BEIGENE Shares Surge Over 4% Post-Earnings on Stellar Q1 Performance

Stock News
·
May 07

Lithium Carbonate Spot Prices Surge Significantly; BEIGENE Reports 178-Fold Jump in Q1 Net Profit

Stock News
·
May 07

Stock Track | BeOne Medicines Soars 5.19% Intraday on Strong Q1 2026 Earnings and Positive Guidance

Stock Track
·
May 06

BEIGENE Reports Q1 2026 Net Profit of 1.608 Billion Yuan

Stock News
·
May 06

GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.3B - $6.5B, vs. FactSet Est of $6.4B

MT Newswires Live
·
May 06

Press Release: BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates

Dow Jones
·
May 06